U

Utah Kidney Research Institute | Salt Lake City, UT

Research site

(Unclaimed)

Location

3702 South State Street, Suite 360, Salt Lake City, Utah, United States of America

Site insights

Top conditions

Top treatments

CCX140-B

Vicadrostat

Povetacicept

GFB-887

Lixivaptan

Retatrutide

RG-012

Empagliflozin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication...

Not yet enrolling

Chronic Kidney Disease

Drug: Placebo matching vicadrostat

Drug: Vicadrostat

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...

Enrolling

Immunoglobulin A Nephropathy

Drug: Placebo (matched to Povetacicept)

Drug: Povetacicept

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Enrolling

Atherosclerotic Cardiovascular Disease (ASCVD)

Chronic Kidney Disease (CKD)

Drug: Retatrutide

Drug: Placebo